Gainers
ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 61.5% to $10.14 after the company presented topline results from Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023.
BridgeBio Pharma, Inc. (NASDAQ: BBIO) gained 60.8% to $29.30 after the company's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy met its primary endpoint.
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 55% to $8.42. LIXTE Biotechnology's preclinical results in collaboration with Netherlands Cancer Institute reveal novel mechanism by which LIXTE's lead clinical compound LB-100 enhances effectiveness of immunotherapy and chemotherapy.
Healthcare Triangle, Inc. (NASDAQ: HCTI) climbed 40.4% to $5.13.
GreenPower Motor Company Inc. (NASDAQ: GP) surged 35.9% to $4.73 after the company reported better-than-expected fourth-quarter financial results.
Nova LifeStyle, Inc. (NASDAQ: NVFY) gained 33.2% to $2.93 after declining over 6% on Friday.
argenx SE (NASDAQ: ARGX) shares jumped 30.8% to $495.75 after reporting topline data from ADHERE study of VYVGART hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.
Rockwell Medical, Inc. (NASDAQ: RMTI) rose 27.3% to $4.06. HC Wainwright & Co. maintained Rockwell Medical with a Buy and raised the price target from $9 to $11.
ZimVie Inc. (NASDAQ: ZIMV) gained 16.3% to $12.65. Traders circulating Deal Reporter post suggesting the company is seeing takeover interest.
Calavo Growers, Inc. (NASDAQ: CVGW) climbed 16% to $35.89. Calavo Growers CEO Lecil E Cole acquired a total of 75,000 shares an average price of $30.34.
EVgo, Inc. (NASDAQ: EVGO) rose 15.7% to $4.6650. EVgo and its eXtend partners were selected by Ohio Department of Transportation for proposed awards of $13.8 million in NEVI funding for 20 fast charging stations along interstate corridors.
PainReform Ltd. (NASDAQ: PRFX) shares gained 15.5% to $9.36. PainReform reported pricing of $1.5 million concurrent registered direct offering and private placement.
Pardes Biosciences, Inc. ...
Related tickers: NVFY, MNPR, BCAN, RKDA, DUO, AWIN, VRAY, PRFX, ALNY, SXTP, BLBX, VIRI, CNSL, CJET, PMN, EVGO, CVGW, ABOS, GBNH, NOVN, GP, UTME, RMTI, ARGX, FYBR, BKI, ZLAB, JZXN, ICG, APLS, STGW, YELP, GNPX, UTRS, UPST, BHC, TIVC, HCTI, ARDS, KSCP, FTCH, LIXT, LEV, PRDS, TMC, PUYI, ZIMV, EVGN, BBIO, WAVS.
Read Full Article